Featured
VialIn stock — dispatched same-day before 2pm
Retatrutide
Triple-agonist GLP-1/GIP/glucagon research peptide
Body-composition researchMetabolic-pathway studiesReceptor-binding studies
€129.99SKU: AV-RETA-V10
1
In stock — dispatched same-day before 2pm
Certificate of Analysis includedUK & EU cold-chain dispatchIn vitro research use only
Research pathwayRetatrutide · catalogued focus areas
Body-composition researchMetabolic-pathway studiesReceptor-binding studies
3 active research areas · 99%+ (HPLC)Batch AVC-2605-0221
Research description
Retatrutide is a triple-agonist GLP-1/GIP/glucagon peptide studied for body-composition and metabolic research. Supplied as a lyophilized powder in a single-use vial, with an independent Certificate of Analysis on every batch. In vitro laboratory research use only.
- Triple GLP-1/GIP/glucagon receptor agonist for combined-pathway research
- Third-party HPLC tested before release
- Available in 10mg or 20mg single-use vials
Regulatory notice
This product is supplied strictly for in vitro laboratory and analytical research. It is not intended for human or veterinary use, and is not a drug, food, or cosmetic under UK or EU law.
Read the full disclaimer→You may also research
Pre-filled Pen · Weight Management
Retatrutide Pen
Pre-filled, dose-locked triple-agonist GLP-1/GIP/glucagon pen
from€249.99In stock
Out of stock
Vial · Weight Management
Semaglutide
GLP-1 receptor agonist research peptide
€69.99Out of stockNext batch ~10 days
Coming soon
Vial · Weight Management
Tirzepatide
Dual agonist (GLP-1 / GIP) research peptide
Launching this quarter